Final Report of a Trial of Intensive versus Standard Blood-Pressure Control
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
BACKGROUND: In a previously reported randomized trial of standard and intensive systolic blood-pressure control, data on some outcome events had yet to be adjudicated and post-trial follow-up data had not yet been collected. METHODS: We randomly assigned 9361 participants who were at increased risk for cardiovascular disease but did not have diabetes or previous stroke to adhere to an intensive treatment target (systolic blood pressure, <120 mm Hg) or a standard treatment target (systolic blood pressure, <140 mm Hg). The primary outcome was a composite of myocardial infarction, other acute coronary syndromes, stroke, acute decompensated heart failure, or death from cardiovascular causes. Additional primary outcome events occurring through the end of the intervention period (August 20, 2015) were adjudicated after data lock for the primary analysis. We also analyzed post-trial observational follow-up data through July 29, 2016. RESULTS: At a median of 3.33 years of follow-up, the rate of the primary outcome and all-cause mortality during the trial were significantly lower in the intensive-treatment group than in the standard-treatment group (rate of the primary outcome, 1.77% per year vs. 2.40% per year; hazard ratio, 0.73; 95% confidence interval [CI], 0.63 to 0.86; all-cause mortality, 1.06% per year vs. 1.41% per year; hazard ratio, 0.75; 95% CI, 0.61 to 0.92). Serious adverse events of hypotension, electrolyte abnormalities, acute kidney injury or failure, and syncope were significantly more frequent in the intensive-treatment group. When trial and post-trial follow-up data were combined (3.88 years in total), similar patterns were found for treatment benefit and adverse events; however, rates of heart failure no longer differed between the groups. CONCLUSIONS: Among patients who were at increased cardiovascular risk, targeting a systolic blood pressure of less than 120 mm Hg resulted in lower rates of major adverse cardiovascular events and lower all-cause mortality than targeting a systolic blood pressure of less than 140 mm Hg, both during receipt of the randomly assigned therapy and after the trial. Rates of some adverse events were higher in the intensive-treatment group. (Funded by the National Institutes of Health; SPRINT ClinicalTrials.gov number, NCT01206062.).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“From the first landmark 1967 Veterans Administration Cooperative Study2 to the 2021 SPRINT trial3, all outcome trials in hypertension have used the average of snapshot BP levels to demonstrate the efficacy of antihypertensive drug therapy in reducing cardiovascular events.”
From Blood pressure and its variability: classic and novel measurement techniques (2022) · cites this paper as [3]
Citations
Cites
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · Nephron · doi:10.1159/000447068 · Cited by 11,717
A Randomized Trial of Intensive versus Standard Blood-Pressure Control
The SPRINT Research Group (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1511939 · Cited by 6,325
Self-citationCox’s regression model for counting processes: A large sample study
Andersen, P. K., & Gill, R. D. (1982) · The Annals of Statistics · doi:10.1214/aos/1176345976 · Cited by 4,419
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
Hebert, L. A., Parikh, S., Prosek, J., Nadasdy, T., & Rovin, B. H. (2013) · American Journal of Nephrology · doi:10.1159/000354390 · Cited by 4,376
Effects of intensive blood-pressure control in type 2 diabetes mellitus
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001286 · Cited by 3,598
Self-citationThe J-Curve Phenomenon in Hypertension
Kang, Y.-Y., & Wang, J.-G. (2016) · Pulse · doi:10.1159/000446922 · Cited by 1,530
A stagewise rejective multiple test procedure based on a modified Bonferroni test
HOMMEL, G. (1988) · Biometrika · doi:10.1093/biomet/75.2.383 · Cited by 1,367
Intensive Blood-Pressure Control in Hypertensive Chronic Kidney Disease
Appel, L. J., Wright, J. T., Greene, T., Agodoa, L. Y., Astor, B. C., Bakris, G. L., Cleveland, W. H., Charleston, J., Contreras, G., Faulkner, M. L., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0910975 · Cited by 719
Ambrosius, W. T., Sink, K. M., Foy, C. G., Berlowitz, D. R., Cheung, A. K., Cushman, W. C., Fine, L. J., Goff, D. C., Johnson, K. C., Killeen, A. A., et al. (2014) · Clinical Trials · doi:10.1177/1740774514537404 · Cited by 544
Holtkamp, F. A., de Zeeuw, D., Thomas, M. C., Cooper, M. E., de Graeff, P. A., Hillege, H. J. L., Parving, H.-H., Brenner, B. M., Shahinfar, S., & Lambers Heerspink, H. J. (2011) · Kidney International · doi:10.1038/ki.2011.79 · Cited by 364
Cited by
Items 201–300 of 462
Fong, J. M. N., Sia, C., & See, K. C. (2025) · Singapore Medical Journal · doi:10.4103/singaporemedj.smj-2025-012 · Cited by 5
Baseline risk and outcome benefit from intensive blood pressure targeting. A systematic review
Verdecchia, P., Angeli, F., & Reboldi, G. (2025) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2025.07.005 · Cited by 5
Sobieraj, P., Nilsson, P. M., & Kahan, T. (2021) · Hypertension · doi:10.1161/hypertensionaha.121.17360 · Cited by 7
The role of blood pressure management in stroke prevention: current status and future prospects
Narita, K., Hoshide, S., & Kario, K. (2022) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2022.2137490 · Cited by 6
Qiu, Y., Ma, J., Zhu, J., Liu, Y., Ren, W., Zhang, S., & Ren, J. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1080682 · Cited by 6
Rationale and design for the Blood Pressure Control Target in Diabetes ( BPROAD ) study
The BPROAD Study Group (2023) · Journal of Diabetes · doi:10.1111/1753-0407.13411 · Cited by 6
Self-citationSarwal, A., Boucher, R. E., Abraham, N., Singh, R., Ye, X., Moghaddam, F. A., Hartsell, S. E., Wei, G., & Beddhu, S. (2023) · Kidney360 · doi:10.34067/kid.0000000000000224 · Cited by 5
Landgraf, R., Aberle, J., Birkenfeld, A. L., Gallwitz, B., Kellerer, M., Klein, H. H., Müller‐Wieland, D., Nauck, M. A., Wiesner, T., & Siegel, E. G. (2023) · Diabetologie und Stoffwechsel · doi:10.1055/a-2076-0024 · Cited by 10
Zhang, K., Song, Q., Bai, J., & Cai, J. (2024) · Hypertension Research · doi:10.1038/s41440-024-01647-1 · Cited by 5
Landgraf, R., Aberle, J., Birkenfeld, A. L., Gallwitz, B., Kellerer, M., Klein, H. H., Müller‐Wieland, D., Nauck, M. A., Wiesner, T., & Siegel, E. G. (2024) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-2166-6755 · Cited by 7
Twala, N., Tade, G., Dessein, P. H., & Teckie, G. (2024) · International Journal of Nephrology and Renovascular Disease · doi:10.2147/ijnrd.s463751 · Cited by 5
Pan, H., Lin, H., Chen, W., & Wang, T. (2022) · Journal of Hypertension · doi:10.1097/hjh.0000000000003100 · Cited by 6
Jiménez-Baladó, J., Llena, I. R., Nafría, C., Pizarro, J., Rodríguez‐Luna, D., Maisterra, O., Ballvé, A., Mundet, X., Violán, C., Ventura, O., et al. (2022) · Journal of Hypertension · doi:10.1097/hjh.0000000000003154 · Cited by 6
Enhanced Primary Care for People With Serious Mental Illness: A Propensity Weighted Cohort Study
Gertner, A. K., Grove, L. R., Swietek, K., Lin, C.-C., Ray, N., Malone, T. L., Rosen, D. L., Zarzar, T. R., Domino, M. E., & Steiner, B. (2023) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.22m14496 · Cited by 5
Frailty and arterial hypertension: clinical practice issues
Kotovskaya, Y. V., & Ткачева, О. Н. (2023) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2023-29-2-246-252 · Cited by 7
KDIGO recommendations on blood pressure management in chronic kidney disease
Subbiah, A., & Bhowmik, D. M. (2022) · Kidney International · doi:10.1016/j.kint.2022.02.036 · Cited by 5
Guo, J., Liu, Y., Liu, X., Yan, M., Zhang, Y., Fang, S., Wang, S., & Yu, B. (2025) · JACC Advances · doi:10.1016/j.jacadv.2025.101678 · Cited by 4
Faconti, L., Tantirige, N. N. T., Poulter, N. R., George, J., Kapil, V., Gupta, A. K., Swift, P. A., Heagerty, A. M., Shantsila, E., Partridge, S., et al. (2025) · Journal of Human Hypertension · doi:10.1038/s41371-025-01055-z · Cited by 4
Anumas, S., Rattanapanop, P., & Pattharanitima, P. (2025) · Renal Failure · doi:10.1080/0886022x.2025.2593732 · Cited by 6
Natalí, L., de la Cruz-Thea, B., Godino, A., Conde, C. B., Peinado, V. I., & Musri, M. M. (2026) · Biomolecules · doi:10.3390/biom16010173 · Cited by 6
Wang, X., & Cai, J. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002236 · Cited by 4
Zolotarova, T., Bilchenko, O. V., Volkov, D., Pasyura, I., & Prylutska, K. (2022) · The Journal of V N Karazin Kharkiv National University series Medicine · doi:10.26565/2313-6693-2022-44-07 · Cited by 4
Hu, Z., Luo, D., Zhou, W., Xu, C., Chen, X.-Z., Zhang, B., Jin, X., Wang, Y., Zhang, J., Wu, H. M., et al. (2024) · BMC Cardiovascular Disorders · doi:10.1186/s12872-024-04168-4 · Cited by 4
Sun, G., Miao, W., Liu, S., Yin, Y., Geng, D., Ye, N., Xie, Z., Zhang, L., Zhou, S., Wang, C., et al. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.19604 · Cited by 4
Gallwitz, B., Aberle, J., Birkenfeld, A. L., KELLERER, M., Klein, H. H., Landgraf, R., Müller‐Wieland, D., Müssig, K., Nauck, M. A., Siegel, E. G., et al. (2025) · Diabetologie und Stoffwechsel · doi:10.1055/a-2592-7923 · Cited by 4
Kim, M. H., Bae, D., Lee, J. H., Lee, D. I., Kim, S. M., Lee, S. Y., Bae, J., Kim, D.-W., Cho, M., Hwang, J., et al. (2022) · Cardiology Journal · doi:10.5603/cj.a2022.0067 · Cited by 4
Ryu, S. I., Lee, S. H., Byoun, H. S., Kim, Y., Bang, J. S., Bang, J. S., Kwon, O.-K., Oh, C. W., & Lee, S. U. (2024) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2024.03.004 · Cited by 5
Zeijen, V. J. M., Peeters, L. E. J., Asman, A., Boersma, E. H., Massey, E. K., van Dijk, L., Daemen, J., & Versmissen, J. (2024) · Journal of Hypertension · doi:10.1097/hjh.0000000000003780 · Cited by 7
Simonenko, M., Hansen, D., Niebauer, J., Volterrani, M., Adamopoulos, S. N., Amarelli, C., Ambrosetti, M., Anker, S. D., Bayés‐Genís, A., Gal, T. B., et al. (2024) · TU/e Research Portal · doi:10.1002/ejhf.3185 · Cited by 8
Mousavi, A., Shojaei, S., Abhari, A. P., Mirhosseini, S. A., Ebrahimi, R., Rajabi, E., Farooqi, M. A., Azizpour, A., Moghadam, S. A., Kuno, T., et al. (2025) · American Journal of Hypertension · doi:10.1093/ajh/hpaf140 · Cited by 4
The need for a unified categorization of hypertension across guidelines
Volpe, M., Guzik, T. J., & Messerli, F. H. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf747 · Cited by 4
Therapeutic Inertia and Racial Differences in Blood Pressure Control—Time to Get Moving
Rivara, M. B., Bansal, N., & Young, B. A. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.43008 · Cited by 4
Hughes, A. D., Eastwood, S. V., Tillin, T., & Chaturvedi, N. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.795267 · Cited by 6
Updates in hypertension: new trials, targets and ways of measuring blood pressure
Salman, L. A., & Cohen, J. B. (2022) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000791 · Cited by 4
How to maximize graft survival
Lim, M. A., & Bloom, R. D. (2022) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000001039 · Cited by 4
Are blood-pressure targets needed to prevent cardiovascular disease?
Schutte, A. E. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00595-4 · Cited by 4
Liu, Y., Su, W., Lin, C.-Y. G., Tsai, C., Su, H., & Chen, S. (2025) · Journal of Clinical Hypertension · doi:10.1111/jch.70013 · Cited by 4
Goupil, R., Tsuyuki, R. T., Santesso, N. A., Terenzi, K. A., Habert, J., Cheng, G., Gysel, S. C., Bruneau, J., Leung, A. A. C., Campbell, N. R. C., et al. (2025) · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada · doi:10.1177/17151635251343907 · Cited by 3
Bacaicoa, M. S., Rico‐Martín, S., Gullón, A., Pardo, J. F., Villa, J., Gutiérrez-Cortizo, E. N., Robles, N. R., del Aguila, J. M., Cunha, P., Vassilenko, V., et al. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.124.038011 · Cited by 4
Importance of Adherence Versus Intensification in Attaining Blood Pressure Control
Sabharwal, P., Rothberg, M. B., & Pfoh, E. R. (2025) · Hypertension · doi:10.1161/hypertensionaha.125.25613 · Cited by 3
Mills, K. T., Ferguson, T., López-López, J., Duncan, J. D., Lanza, P., Marshall, A. N., Reyes, M. M., Chen, J., Anderson, A. H., Whelton, P. K., et al. (2025) · American Heart Journal · doi:10.1016/j.ahj.2025.107329 · Cited by 3
Cai, A., Bayés‐Genís, A., & Parati, G. (2026) · Journal of Human Hypertension · doi:10.1038/s41371-026-01123-y · Cited by 5
Ai, Z., Liu, H., Lin, W., Hu, P., Zhou, Q., Tian, F., Rao, M., Zhuang, Z., Liu, X., Wei, S., et al. (2026) · Atmospheric Environment · doi:10.1016/j.atmosenv.2026.121928 · Cited by 3
Lyu, Y., Bian, W., Liu, Y., Liu, Y., Zhang, J., Song, Z., Liu, Y., Chen, T., & Li, C. (2026) · Hypertension · doi:10.1161/hypertensionaha.125.26397 · Cited by 3
Gori, M., Marini, M., Gonzini, L., Carigi, S., Gennaro, L. D., Gentile, P., Leonardi, G., Orso, F., Tinti, M. D., Lucci, D., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11226627 · Cited by 3
Critical Appraisal of Randomized Controlled Trials: An Overview
Maheshwarappa, H. M., & Majumder, S. (2023) · Indian Journal of Respiratory Care · doi:10.5005/jp-journals-11010-1040 · Cited by 3
Liu, X., Lin, B., Yao, S., & Pan, Z. (2024) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2501006 · Cited by 3
Masuda, M., TOBITA, K., Goda, A., Fujisawa, D., TAKEUCHI, S., Koyama, K., Tashiro, S., Yamada, S., Soejima, K., & KOHNO, T. (2024) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2024.11.013 · Cited by 3
Wu, S., Jiang, S., Yao, Y., & Li, M. (2025) · Coronary Artery Disease · doi:10.1097/mca.0000000000001545 · Cited by 4
Cheon, D. Y., Han, K., Lee, Y. J., Lee, J. H., Park, M. S., Lee, S. J., Han, S., Choi, J.-H., & Lee, M. (2025) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaf573 · Cited by 5
Systolic Blood Pressure Time in Target Range and Acute Kidney Injury in Patients With Hypertension
Chen, W., Yang, C. X., Chen, Y., Li, Z.-J., Guan, K., Li, J., & Huang, R. (2025) · Hypertension · doi:10.1161/hypertensionaha.125.25511 · Cited by 5
Sud, M. K., Chu, A., Austin, P. C., Naimark, D. M. J., Thanassoulis, G., Wijeysundera, H. C., & Ko, D. T. (2022) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcac044 · Cited by 3
Kobayashi, A., Fujihara, K., Yamada, M. H., Sato, T., Yaguchi, Y., Kitazawa, M., Matsubayashi, Y., Iwanaga, M., Yamada, T., Kodama, S., et al. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003362 · Cited by 3
Planting a path to kidney health: The vegetarian diet and diabetic nephropathy
Maqbool, M., Dar, M. A., & Ara, I. (2023) · Open Health · doi:10.1515/ohe-2023-0011 · Cited by 3
Liu, Y., Mi, B., Pei, L., Dang, S., Yan, H. G., & Li, C. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1443104 · Cited by 3
Li, H., He, Q., Wenqing, Z., Yanjun, Z., Wangjia, P., Yu, S., Zhuoga, D., Zhang, Y., & Zhao, Y. (2025) · ESC Heart Failure · doi:10.1002/ehf2.15232 · Cited by 3
Intensive systolic blood pressure control in patients with or without worsening renal function
Xu, X., Zhang, X., Wang, S., Wang, K., Yu, X. Y., Zhu, Y., Zhao, X., Wang, Y., Meng, X., Zhao, Z., et al. (2025) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaf184 · Cited by 3
Chen, X., Wang, L., Jiang, Y., Tang, W., Xiao, J., Deng, W., Ren, X., & Li, C. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1508667 · Cited by 4
Manejo da hipertensão arterial no diabetes
Izar, M. C. D. O., Fonseca, F. A. H., Faludi, A. Á., de Araújo, D. B., & Bertoluci, M. C. (2022) · Conectando Pessoas eBooks · doi:10.29327/557753.2022-16 · Cited by 5
Won, K., Park, H., Heo, R., Lee, B. K., Lin, F. Y.-H., Hadamitzky, M., Kim, Y.-J., Sung, J. M., Conte, E., Andreini, D., et al. (2022) · Clinical Cardiology · doi:10.1002/clc.23870 · Cited by 3
Eschenhagen, T., & Weil, J. (2022) · Springer eBooks · doi:10.1007/978-3-662-66303-5_6 · Cited by 3
Dasa, O., Smith, S. M., & Pepine, C. J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-88369-6.00033-5 · Cited by 4
Evidence-based Clinical Practice Guideline for Chronic Kidney Disease 2023
Kihara, M., & Suzuki, Y. (2025) · Health Evaluation and Promotion · doi:10.7143/jhep.52.362 · Cited by 2
Islam, Q. T., Haque, K. S., Moula, K., Azad, K. A. K., Ahasan, H. A. M. N., Rahman, M. M., Patwary, M. I., Hossain, Z., Azad, A. K., & Miah, T. (2025) · Cureus · doi:10.7759/cureus.92756 · Cited by 3
Takada, S., Wali, S., Park, N. J., Sadia, A., Weldon, A. R., Liang, L.-J. F., Vassar, S. D., Carson, S. L., Dopp, A. R., Korn, A. R., et al. (2025) · Implementation Science · doi:10.1186/s13012-025-01452-5 · Cited by 2
Chronic kidney disease for the primary care provider
Doak, W., Lerma, E. V., & Shah, A. D. (2025) · Disease-a-Month · doi:10.1016/j.disamonth.2025.102027 · Cited by 2
Blood pressure, proteomic vascular ageing, and incident cardiovascular disease
Kou, M., Wang, X., Ma, H., Heianza, Y., DORANS, K. S., Bazzano, L., & Li, X. (2025) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaf757 · Cited by 3
Challenges in validation studies of blood pressure measurement devices
Takahashi, H., & Asayama, K. (2025) · Blood Pressure Monitoring · doi:10.1097/mbp.0000000000000777 · Cited by 2
European Hypertension Guidelines: Similarities and What the Practicing Physician Should Keep in Mind
Zeniodi, M. E., Τσαγανός, Θ., Menti, A., Komnianou, A., Κόλλιας, Α., & Stambolliu, E. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15020859 · Cited by 4
The Statin Floor Effect: a Mechanistic Framework for Residual Cardiovascular Risk
Peacock, E. J. (2026) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-025-07827-6 · Cited by 2
Okamoto, H., Matsukuma, Y., Ataka, E., Ueki, K., Tsuchimoto, A., Masutani, K., Noguchi, H., Kaku, K., Yamada, S., Nakamura, M., et al. (2026) · Hypertension Research · doi:10.1038/s41440-026-02553-4 · Cited by 2
Extension Reports in Clinical Trials
Rosselló, X., Pocock, S., Taylor, D., Bhatt, D. L., Hameed, I., Rockhold, F. W., Skoza, W. A., & Gaudino, M. F. L. (2026) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.12.012 · Cited by 2
Adolescent Blood Pressure and Cardiovascular Disease Before Age 50 Years
Tsur, A. M., Talmy, T., Hershenson, R., Fishman, B., Derazne, E., Tzur, D., Pinhas‐Hamiel, O., Vivante, A., Grossman, E., Furer, A., et al. (2026) · Hypertension · doi:10.1161/hypertensionaha.125.26414 · Cited by 2
Hypertensive Heart Disease and HFpEF: What We Have Learned in the Last Decade
Ono, R., & Falcão, L. M. (2026) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2026.04.006 · Cited by 3
Three‐Year Durability of Radiofrequency Renal Denervation: SPYRAL HTN‐ON MED
Kandzari, D. E., Mahfoud, F., Townsend, R. R., Kario, K., Weber, M. A., Schmieder, R. E., Tsioufis, K. P., Pocock, S., Yang, G., Brar, S. K., et al. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.126.049081 · Cited by 3
Cheng, H., Yeh, C., Wu, C., Chen, M. Y., Chang, Y., Tsai, H.-H., Chen, Z.-W., Lee, H.-C., Pan, H., Hsu, R.-Y., et al. (2026) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2026.09.040 · Cited by 2
A tailored cardiac rehabilitation for patients with acute heart failure
Robson, A. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00580-x · Cited by 2
Salvador, V. D., & Bakris, G. L. (2021) · American Heart Journal Plus Cardiology Research and Practice · doi:10.1016/j.ahjo.2021.100079 · Cited by 2
Whelton, P. K., Bundy, J. D., & Carey, R. M. (2022) · American Journal of Hypertension · doi:10.1093/ajh/hpac045 · Cited by 2
Liu, Y., Chen, S., Lee, W.-H., Chen, Y., Hsu, P., Tsai, W., Lee, C., Lin, T., Hung, C., Kuo, C., et al. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192416525 · Cited by 2
Most Recent Trials and Advances in Hypertension
Rey-Rañal, E. M., & Cordero, A. (2022) · European Cardiology Review · doi:10.15420/ecr.2022.27 · Cited by 2
Cascajero, M. Á. A., Alonso‐Safont, T., & Martín‐Fernández, J. (2023) · Revista Clínica de Medicina de Familia · doi:10.55783/rcmf.160104 · Cited by 2
Intensive blood pressure control in older patients with hypertension—a STEP in the right direction?
Liang, X., Chou, O. H. I., & Cheung, B. M. Y. (2023) · Postgraduate Medical Journal · doi:10.1093/postmj/qgad011 · Cited by 2
Optimal target blood pressure in older patients with hypertension
Kim, K. (2023) · Cardiovascular Prevention and Pharmacotherapy · doi:10.36011/cpp.2023.5.e4 · Cited by 3
Feng, X., Yan, M., Tang, L.-H., Zhou, D., Wu, S., Cai, J., & Feng, Y. (2023) · Clinical Cardiology · doi:10.1002/clc.24172 · Cited by 2
Tatami, Y., Tanaka, A., Ohashi, T., Kubota, R., Kaneko, S., Shinoda, M., Uemura, Y., Takagi, K., Tanaka, M., Umemoto, N., et al. (2024) · Heart and Vessels · doi:10.1007/s00380-024-02369-7 · Cited by 2
Is Intensive Blood Pressure Control Indicated in Older Patients with Hypertension?
Htay, T., Lane, M., Khanjani, N., Mianroodi, A. A., & Ream-Winnick, S. (2024) · Current Cardiology Reports · doi:10.1007/s11886-024-02080-z · Cited by 2
Katsoulis, M., Leyrat, C., Hingorani, A. D., & Gomes, M. (2024) · Epidemiology · doi:10.1097/ede.0000000000001766 · Cited by 3
Arterial hypertension management: modern approaches and prospects
Сергеевич, Р. А., Moscow, R. F., Kechina, O. V., & Владимировна, М. М. (2024) · Therapist’s Bulletin · doi:10.31550/2712-8601-vt-2024-4-4 · Cited by 2
Tian, X., Zhang, X., Chen, S., Xia, X., Xu, Q., Wang, Y., Wu, S., & Wang, A. (2025) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2024.08.012 · Cited by 3
Eschenhagen, T., & Weil, J. (2025) · Springer eBooks · doi:10.1007/978-3-662-70594-0_6 · Cited by 2
Wang, X., Hu, Y., Huan, J.-M., Liang, S.-B., Xin, L., Jiang, F., Hua, Z., Wang, Z., Kong, L.-H., Wu, Q., et al. (2025) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-025-4007-6 · Cited by 2
Optimizing Nephron Performance: The Old, the New, and the New–Old Diuretic Therapies
Fuchs, F. D., Procianoy, G. S., Bottino, L. G., Fuchs, S. C. P. C., & Whelton, P. K. (2025) · Biomedicines · doi:10.3390/biomedicines13061413 · Cited by 3
Zhang, W., Liu, Y., Feng, Z., Xiong, N., Tang, L., Zhu, X., Xue, J., Chen, W., & Dai, W. (2025) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2025.104279 · Cited by 2
Lin, B., Liu, X., Yao, S., & Pan, Z. (2023) · International Journal of Hypertension · doi:10.1155/2023/7533353 · Cited by 2
Association of baseline serum cholesterol with benefits of intensive blood pressure control
Wang, X., Feng, Y., Yang, L., Zhang, G., Tian, X., Ling, Q., Tan, J., & Cai, J. (2023) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002474 · Cited by 2
Shi, S., Gouskova, N., Park, C. M., Travison, T. G., Wei, L., & Kim, D. H. (2023) · The American Journal of Medicine · doi:10.1016/j.amjmed.2023.09.003 · Cited by 2
Time‐weighted blood pressure with cardiovascular risk among patients with or without diabetes
Jiang, Z., Shao, F., Hu, J., Zhuang, Q., Cooray, P. L. R. K., Chen, K., Wu, Z., Chen, T., & Li, C. (2024) · Clinical Cardiology · doi:10.1002/clc.24213 · Cited by 2
Importance of reconfirming the validity of the revised blood pressure categories
Asayama, K. (2023) · Hypertension Research · doi:10.1038/s41440-023-01206-0 · Cited by 2
Time to Reconsider Ejection Fraction in Heart Failure
Seo, Y. (2023) · JACC Asia · doi:10.1016/j.jacasi.2023.07.001 · Cited by 2
Metadata
- Authors
- The SPRINT Research Group
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- The SPRINT Research Group
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2021-05-20
- Volume
- 384
- Issue
- 20
- Pages
- 1921-1930
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC9907774
- OpenAlex
- W3161638097
- Cited by
- 454
- References
- 20
- Citations by year
- 2026: 74 · 2025: 92 · 2024: 74 · 2023: 83 · 2022: 105 · 2021: 26
- FWCI
- 48.27
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health, National Heart, Lung, and Blood Institute
- National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases
- NIH, National Institute on Aging
- NIH, National Institute of Neurological Disorders and Stroke
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Keywords
- intensive blood pressure control, systolic blood pressure target, antihypertensive therapy, major adverse cardiovascular events, all-cause mortality, cardiovascular risk, adverse events, acute kidney injury, heart failure, post-trial follow-up, SPRINT trial, acute coronary syndrome, stroke, myocardial infarction, syncope, electrolyte imbalance, hypotension
- MeSH terms
- Aged, Antihypertensive Agents, Blood Pressure, Cardiovascular Diseases, Female, Follow-Up Studies, Humans, Hypertension, Male, Middle Aged
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.